PACB | tickerfilter.com

Fundamental analysis

21%

Profitability 0%

Dept financing 19%

Liquidity 75%

Performance 30%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-12.18%

1 Month

-33.17%

3 Months

-29.38%

6 Months

-75.40%

1 Year

-87.78%

2 Year

-75.40%

Key data

Stock price

$1.38

P/E Ratio

-0.93

DAY RANGE

N/A - N/A

EPS

-$1.50

52 WEEK RANGE

$1.16 - $11.96

52 WEEK CHANGE

-$0.88

MARKET CAP

373.365 M

YIELD

N/A

SHARES OUTSTANDING

272.529 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/06/2024

BETA

3.07

PUBLIC FLOAT

AVERAGE 10 VOLUME

$6,175,198

AVERAGE 30 VOLUME

$7,597,359

Company detail

CEO:
Region: US
Website: pacificbiosciences.com
Employees: 699
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.

PACB - Pacific Biosciences of California Inc